Longyang Jiang

2.7k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

Longyang Jiang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Longyang Jiang has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Longyang Jiang's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (11 papers). Longyang Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (11 papers). Longyang Jiang collaborates with scholars based in China, United States and Japan. Longyang Jiang's co-authors include Jacob M. Taylor, Anders S. Sørensen, Mikhail D. Lukin, Minjie Wei, Lin Zhao, Miao He, Wenzhong Shen, Yan Wang, Qian Wei and Jia Bi and has published in prestigious journals such as Applied Physics Letters, Journal of Applied Physics and Oncogene.

In The Last Decade

Longyang Jiang

48 papers receiving 2.0k citations

Hit Papers

Strain-Induced Pseudo-Magnetic Fields Greater Than 300 Te... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longyang Jiang China 23 837 782 571 452 260 54 2.0k
Meng Ye China 31 2.2k 2.6× 453 0.6× 382 0.7× 581 1.3× 1.1k 4.1× 81 3.4k
Xiaowei Zhang China 25 1.0k 1.2× 422 0.5× 159 0.3× 675 1.5× 638 2.5× 97 2.3k
Masahiro Kimura Japan 22 203 0.2× 715 0.9× 381 0.7× 93 0.2× 240 0.9× 151 1.9k
Ping Miao China 20 421 0.5× 548 0.7× 458 0.8× 68 0.2× 200 0.8× 83 1.6k
Yilei Li China 16 823 1.0× 555 0.7× 136 0.2× 297 0.7× 573 2.2× 44 1.8k
R. Atkinson United Kingdom 19 271 0.3× 477 0.6× 174 0.3× 404 0.9× 234 0.9× 46 2.3k
Tingwei Zhang China 19 716 0.9× 337 0.4× 91 0.2× 892 2.0× 27 0.1× 45 1.8k
Hirotaka Oshima Japan 20 285 0.3× 252 0.3× 64 0.1× 390 0.9× 325 1.3× 106 1.3k
Haowei He China 15 517 0.6× 205 0.3× 162 0.3× 136 0.3× 100 0.4× 38 1.2k

Countries citing papers authored by Longyang Jiang

Since Specialization
Citations

This map shows the geographic impact of Longyang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longyang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longyang Jiang more than expected).

Fields of papers citing papers by Longyang Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longyang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longyang Jiang. The network helps show where Longyang Jiang may publish in the future.

Co-authorship network of co-authors of Longyang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Longyang Jiang. A scholar is included among the top collaborators of Longyang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longyang Jiang. Longyang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Hui, Xuping Yang, Guoqian Li, et al.. (2025). Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas. Frontiers in Immunology. 15. 1488894–1488894. 1 indexed citations
2.
Jiang, Longyang, Rui Wang, Jianyong Sun, et al.. (2024). A 100 W-level ultra-narrow fiber-coupled 780 nm diode laser. High Power Laser Science and Engineering. 12. 1 indexed citations
3.
Jiang, Longyang, et al.. (2024). Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinoma. Translational Cancer Research. 13(11). 5983–5994.
4.
Wang, Lin, Xueping Li, Longyang Jiang, et al.. (2021). Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer. Pathology & Oncology Research. 27. 596899–596899. 11 indexed citations
5.
Song, Xinyue, Xue Jiao, Yan Han, et al.. (2021). Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity. Frontiers in Cell and Developmental Biology. 9. 622018–622018. 15 indexed citations
6.
Song, Xinyue, Lin Wang, Mingyi Ju, et al.. (2021). m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Frontiers in Oncology. 11. 598017–598017. 10 indexed citations
7.
Wei, Xin, et al.. (2021). Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC. Pathology & Oncology Research. 27. 585192–585192. 8 indexed citations
8.
Ju, Mingyi, Longyang Jiang, Wei Qian, et al.. (2021). A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer. OncoTargets and Therapy. Volume 14. 5065–5083. 13 indexed citations
9.
Zhao, Lin, Longyang Jiang, Ming Zhang, et al.. (2021). NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay. Oncogene. 40(30). 4919–4929. 26 indexed citations
10.
Ju, Mingyi, Jia Bi, Qian Wei, et al.. (2020). Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer. Briefings in Bioinformatics. 22(4). 118 indexed citations
11.
Ju, Mingyi, Jia Bi, Lan Zhao, et al.. (2020). A five‐mRNA signature associated with post‐translational modifications can better predict recurrence and survival in cervical cancer. Journal of Cellular and Molecular Medicine. 24(11). 6283–6297. 14 indexed citations
12.
Yu, Lifeng, Xinyue Song, Jia Bi, et al.. (2019). Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. Cell Death and Disease. 10(9). 666–666. 22 indexed citations
13.
Zhu, Wenjing, Miao He, Liwen Zhang, et al.. (2019). SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway. Journal of Translational Medicine. 17(1). 259–259. 46 indexed citations
14.
Han, Qiang, Mingli Sun, Wensi Liu, et al.. (2019). <p>Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer</p>. OncoTargets and Therapy. Volume 12. 1749–1763. 11 indexed citations
15.
Jiang, Longyang, Qian Wei, Jia Bi, et al.. (2018). Identification of a novel cell cycle‐related gene signature predicting survival in patients with gastric cancer. Journal of Cellular Physiology. 234(5). 6350–6360. 58 indexed citations
16.
Song, Xinyue, Chaoran Zhao, Longyang Jiang, et al.. (2018). High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis. Pathology - Research and Practice. 214(12). 2046–2053. 24 indexed citations
17.
Sang, Liang, et al.. (2017). Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model. World Journal of Gastroenterology. 23(47). 8334–8344. 45 indexed citations
18.
Zhao, Lin, Yan Wang, Longyang Jiang, et al.. (2016). MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). Journal of Experimental & Clinical Cancer Research. 35(1). 25–25. 73 indexed citations
19.
Jiang, Qian, Miao He, Shu Guan, et al.. (2015). MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Tumor Biology. 37(4). 5001–5011. 77 indexed citations
20.
Jiang, Qian, Miao He, Mengtao Ma, et al.. (2015). MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1. Oncology Reports. 35(3). 1425–1432. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026